Cadila Pharmaceuticals to invest Rs 100 crore in Odisha

A production facility for pharmaceutical formulations will be built at Malipada, close to Bhubaneswar in Odisha, thanks to an investment of 100 crore by Cadila Pharmaceuticals of Ahmedabad.

The company claims that at the Make in Odisha Conclave 2022 in Bhubaneswar, it signed an investment intention form (IIF) with the Odisha government.

According to the company, the projected greenfield state-of-the-art plant will be one of the largest pharmaceutical manufacturing facilities in the area and will receive quick permissions from the State government.

Site Moved. Visit our New Website

We have moved this news site from this URL to https://www.newprojectstracker.com/capex-news .

Visit this site for regular updates

Buy Latest Research Reports

Jayaparakash Sampath

Founder & CEO at NPT Research Information Services

Related Posts